Drugs / GCFLU Quadrivalent Inj.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02915809 Comparator | Oct → Dec 2016 | influenza | Green Cross Corporation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCFLU Quadrivalent Inj. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02915809 ↗ |
| Modality | Vaccine | “GCFLU Quadrivalent Inj. vaccine” NCT02915809 ↗ |
| Route | Intramuscular | “0.5mL, Intramuscular” NCT02915809 ↗ |